Arkolith/Insider Trading/EBS/Form 4

Richard Ronald

DirectorEmergent BioSolutions Inc. (EBS) · full profile →Form 4 · filed Dec 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$263K
Net Open-Market Flow
-$263K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 5, 2025Sell(S)15K$11.90$177K98K
Dec 5, 2025Tax withholding(F)11K$11.90$129K113K
Dec 5, 2025Option exercise(M)26K$5.02$129K124K
Dec 5, 2025Sell(S)7K$12.11$86K98K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 5, 2025Option exercise(M)26K—$00

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001380177-25-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML